By Tina Rosenberg
My column on making Naloxone available over-the-counter to reverse overdoses drew many plaudits and two main strands of criticism. One group argued that addicts aren’t worth saving and we need to cut the drug supply; the other said that Naloxone, also known by its brand name, Narcan, is too risky to be available without a prescription.
Let me address the second argument first. More than 50,000 Naloxone kits have already been distributed to drug users, pain patients and their loved ones in the United States and 10,000 successful overdose reversals have been reported.